Stock QIAGEN NV
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Qiagen NV Deutsche Boerse AG

Equities

NL0000240000

End-of-day quote Deutsche Boerse AG
Other stock markets
- EUR - Intraday chart for Qiagen NV
11:57am Wolfe Research Upgrades Qiagen to Outperform From Peer Perform, Price Target is $50 MT
06-21 Qiagen Seeks M&A CI

Chart calendar Qiagen NV

047a044313835fc2dad.kuFxxLv4tQlKH47DynyPfli2-5q4RcB5aFg_0ohWl9s.wNU1g4LB5Hsnd_-EjR7_FDv5vtT8A_YvNx5agf0V74KnhQjw9pbRbxtJ3w~d5b1b48f32ad6ade50fc074093b546a9

Upcoming events on Qiagen NV

05/08/2024 Q2 2024 Earnings Release (Projected)
29/10/2024 Q3 2024 Earnings Release (Projected)
10/02/2025 Q4 2024 Earnings Release (Projected)
04/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Qiagen NV

26/06/2024 08:00 Stifel European Healthcare Summit
21/06/2024 09:00 Annual General Meeting
17/06/2024 17:00 Capital Markets Day
22/05/2024 08:00 Deutsche Bank dbAccess European Champions Conference
15/05/2024 09:00 Berenberg MDx Day
30/04/2024 14:00 Q1 2024 Earnings Call
29/04/2024 21:05 Q1 2024 Earnings Release
04/04/2024 American Association for Cancer Research Meeting
26/03/2024 13:00 BNP Exane Healthcare Conference
05/03/2024 19:10 TD Cowen Health Care Conference
27/02/2024 08:00 UBS European Healthcare Conference
26/02/2024 08:00 Morgan Stanley European MedTech and Life Sciences Conference
07/02/2024 14:00 Q4 2023 Earnings Call
06/02/2024 21:05 Q4 2023 Earnings Release
29/01/2024 Reverse Split: 24.25 of 25
29/01/2024 Capital return instalment
15/01/2024 15:00 German Corporate Conference
12/01/2024 08:00 ODDO BHF Forum
09/01/2024 14:00 Commerzbank and ODDO BHF German Investment Conference
08/01/2024 21:30 JPMorgan Healthcare Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		1 526
1 526
0.06%		1 870
1 858
0.68%		2 252
2 198
2.44%		2 142
2 139
0.12%		1 965
1 960
0.26%
2 001

EBITDA
Million USD		Released
Forecast
Spread 		552
532
3.7%		748
723
3.4%		884
870
1.67%		790
791
-0.14%		659
675
-2.34%
721

EBIT
Million USD		Released
Forecast
Spread 		422
412
2.5%		627
623
0.57%		755
714
5.73%		656
654
0.33%		529
524
0.88%
565

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-77,8
-77,9
0.13%		439
364
20.66%		626
564
11.04%		513
538
-4.72%		430
437
-1.7%
505

Net income
Million USD		Released
Forecast
Spread 		-41,5
-29,5
-40.57%		359
294
22.31%		513
475
7.83%		423
424
-0.14%		341
344
-0.65%
402

EPS
USD		Released
Forecast
Spread 		-0,19
-0,11
-62.85%		1,58
1,30
20.88%		2,28
2,17
4.8%		1,90
1,96
-2.99%		1,48
1,54
-3.96%
1,81

Announcement Date04/02/2009/02/2108/02/2210/02/2306/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD		Released
Forecast
Spread 		628
591
6.36%		516
500
3.15%		500
482
3.71%		498
486
2.55%		485
479
1.41%		495
493
0.38%		476
471
1.07%		509
504
1.01%		459
457
0.41%
495


503


533


488


522

EBITDA
Million USD		Released
Forecast
Spread 		266
240
11.11%		179
165
8.14%		176
158
11.2%		169
164
2.57%		158
163
-3.31%		168
194
-13.27%		158
149
5.95%		175
175
-0.02%		153
150
1.93%
172


183


201


170


183

EBIT
Million USD		Released
Forecast
Spread 		232
205
13.24%		146
133
10.33%		144
129
11.06%		135
128
5.61%		124
123
0.65%		136
134
1.4%		126
127
-0.37%		142
139
2.34%		118
117
0.49%
136


144


163


132


150

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread





95,7
94,5
1.29%
































Net income
Million USD		Released
Forecast
Spread 		155
138
12.44%		96,7
78,2
23.67%		82,4
78,1
5.44%		88,8
73,7
20.58%		85,0
75,1
13.24%		80,8
86,1
-6.2%		77,8
84,7
-8.14%		97,7
92,3
5.76%		80,7
76,3
5.79%
91,8


95,7


112







EPS
USD		Released
Forecast
Spread 		0,69
0,62
12.09%		0,43
0,36
21.29%		0,37
0,35
6.42%		0,40


0,38
0,33
14.04%		0,36
0,37
-2.98%		0,35
0,38
-8.76%		0,42
0,41
3.43%		0,36
0,34
6.88%
0,44


0,48


0,53


0,41


0,47

Announcement Date27/04/2226/07/2207/11/2210/02/2303/05/2308/08/2330/10/2306/02/2429/04/24-----

Upcoming sector events for Qiagen NV

15/07/2024 06:45 ADDLIFE AB: Q2 2024 Earnings Release
21/07/2024 MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
23/07/2024 SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected)
23/07/2024 ALKERMES PLC: Q2 2024 Earnings Release (Projected)
23/07/2024 IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected)
23/07/2024 ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected)
24/07/2024 LONZA GROUP AG: Q2 2024 Earnings Release
25/07/2024 06:00 BACHEM HOLDING AG: Q2 2024 Earnings Release
25/07/2024 PHARVARIS N.V.: Q2 2024 Earnings Release (Projected)
26/07/2024 06:00 BB BIOTECH AG: Q2 2024 Earnings Release
More events

Past sector events for Qiagen NV

07/06/2024 07:57 POLARIS GROUP: May 2024 Sales and Revenue Release
29/05/2024 21:01 IMMUNOVANT, INC.: Q4 2024 Earnings Release
23/05/2024 12:00 CUREVAC N.V.: Q1 2024 Earnings Release
22/05/2024 06:00 EVOTEC SE: Q1 2024 Earnings Release
21/05/2024 22:14 ALVOTECH: Q1 2024 Earnings Release
21/05/2024 12:00 EXSCIENTIA PLC: Q1 2024 Earnings Release
17/05/2024 07:00 BIOARCTIC AB: Q1 2024 Earnings Release
15/05/2024 21:05 CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release
15/05/2024 12:00 PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release
14/05/2024 GNI GROUP LTD.: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. QGEN Stock
  4. Stock
  5. Calendar Qiagen NV